|
Company Description
Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
Systems using xMAP technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Luminex Vision Statement
Multiplexed Solutions. For Life.
Career Opportunities
Luminex is always looking for a few good people.
Read the job listings. Submit a resume.
Visitor Information
Find out how to get to Luminex and where to stay.
Investor Relations
Luminex is a publicly traded company on the NASDAQ Stock Market under the symbol “LMNX".
Events
Learn more about the exhibitions and conferences Luminex will attend.
|
|
